Life sciences news
-
Bone Therapeutics reaches 50% treated patients in ongoing JTA-004 Phase III pivotal knee osteoarthritis study
Tuesday October 20th 2020
Read more
-
Mithra signs LSA for commercialization of Estelle® in North Africa
Monday October 19th 2020
Read more
-
CANNOVEX receives EUR 0.5 million grant for development of nanofibrous films for transmucosal uptake of cannabinoids
Monday October 19th 2020
Read more
-
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
Friday October 16th 2020
Read more
-
New players at the synapse
Friday October 16th 2020
Read more
-
Sequana Medical appoints two additional experts as Heart Failure Scientific Advisors
Thursday October 15th 2020
Read more
-
Prof. Sarah-Maria Fendt is awarded the EMBO Gold Medal
Thursday October 15th 2020
Read more
-
Oxurion NV appoints Tom Graney, CFA as Chief Financial Officer
Wednesday October 14th 2020
Read more
-
Become a flanders.bio member
Your news here?
-
Bone Therapeutics’ allogeneic cell therapy product, ALLOB, shows 90% fusion rate at 24 months in Phase IIa study in lumbar spinal fusion
Wednesday October 14th 2020
Read more
-
Phase 2B/3 Trial shows efficacy of Filgotinib for the induction and maintenance of remission in moderately and severely active Ulcerative Colitis
Tuesday October 13th 2020
Read more
-
Sanquin finds investors for plasma-derived medicines manufacturing subsidiaries Plasma Industries and Plasma Products
Tuesday October 13th 2020
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
